Literature DB >> 11342433

Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner.

M Majka1, A Janowska-Wieczorek, J Ratajczak, K Ehrenman, Z Pietrzkowski, M A Kowalska, A M Gewirtz, S G Emerson, M Z Ratajczak.   

Abstract

The aim of this study was to explore further the hypothesis that early stages of normal human hematopoiesis might be coregulated by autocrine/paracrine regulatory loops and by cross-talk among early hematopoietic cells. Highly purified normal human CD34(+) cells and ex vivo expanded early colony-forming unit-granulocyte-macrophage (CFU-GM)-derived, burst forming unit-erythroid (BFU-E)-derived, and CFU-megakaryocyte (CFU-Meg)-derived cells were phenotyped for messenger RNA expression and protein secretion of various growth factors, cytokines, and chemokines to determine the biological significance of this secretion. Transcripts were found for numerous growth factors (kit ligand [KL], FLT3 ligand, fibroblast growth factor-2 [FGF-2], vascular endothelial growth factor [VEGF], hepatocyte growth factor [HGF], insulinlike growth factor-1 [IGF-1], and thrombopoietin [TPO]); cytokines (tumor necrosis factor-alpha, Fas ligand, interferon alpha, interleukin 1 [IL-1], and IL-16); and chemokines (macrophage inflammatory protein-1alpha [MIP-1alpha], MIP-1beta, regulated upon activation, normal T cell expressed and secreted [RANTES], monocyte chemotactic protein-3 [MCP-3], MCP-4, IL-8, interferon-inducible protein-10, macrophage-derived chemokine [MDC], and platelet factor-4 [PF-4]) to be expressed by CD34(+) cells. More importantly, the regulatory proteins VEGF, HGF, FGF-2, KL, FLT3 ligand, TPO, IL-16, IGF-1, transforming growth factor-beta1 (TGF-beta1), TGF-beta2, RANTES, MIP-1alpha, MIP-1beta, IL-8, and PF-4 were identified in media conditioned by these cells. Moreover, media conditioned by CD34(+) cells were found to inhibit apoptosis and slightly stimulate the proliferation of other freshly isolated CD34(+) cells; chemo-attract CFU-GM- and CFU-Meg-derived cells as well as other CD34(+) cells; and, finally, stimulate the proliferation of human endothelial cells. It was also demonstrated that these various hematopoietic growth factors, cytokines, and chemokines are expressed and secreted by CFU-GM-, CFU-Meg-, and BFU-E-derived cells. It is concluded that normal human CD34(+) cells and hematopoietic precursors secrete numerous regulatory molecules that form the basis of intercellular cross-talk networks and regulate in an autocrine and/or a paracrine manner the various stages of normal human hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342433     DOI: 10.1182/blood.v97.10.3075

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  134 in total

1.  Complement C1q enhances homing-related responses of hematopoietic stem/progenitor cells.

Authors:  Ali Jalili; Leah Marquez-Curtis; Neeta Shirvaikar; Marcin Wysoczynski; Mariusz Ratajczak; Anna Janowska-Wieczorek
Journal:  Transfusion       Date:  2010-09       Impact factor: 3.157

Review 2.  CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.

Authors:  Alexander R Mackie; Douglas W Losordo
Journal:  Tex Heart Inst J       Date:  2011

Review 3.  Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusion.

Authors:  Ann Zeuner; Fabrizio Martelli; Stefania Vaglio; Giulia Federici; Carolyn Whitsett; Anna Rita Migliaccio
Journal:  Stem Cells       Date:  2012-08       Impact factor: 6.277

4.  Heat therapy promotes the expression of angiogenic regulators in human skeletal muscle.

Authors:  Alisha M Kuhlenhoelter; Kyoungrae Kim; Dustin Neff; Yaohui Nie; A Nicole Blaize; Brett J Wong; Shihuan Kuang; Julianne Stout; Qifan Song; Timothy P Gavin; Bruno T Roseguini
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-06-29       Impact factor: 3.619

Review 5.  The promise of cell-based therapies for diabetic complications: challenges and solutions.

Authors:  Yagna P R Jarajapu; Maria B Grant
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

Review 6.  Targeting microvasculature for neuroprotection after SCI.

Authors:  Janelle M Fassbender; Scott R Whittemore; Theo Hagg
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 7.  Chronic Histopathological and Behavioral Outcomes of Experimental Traumatic Brain Injury in Adult Male Animals.

Authors:  Nicole D Osier; Shaun W Carlson; Anthony DeSana; C Edward Dixon
Journal:  J Neurotrauma       Date:  2015-04-15       Impact factor: 5.269

Review 8.  Stem cells and their potential clinical applications in psychiatric disorders.

Authors:  Mariusz Z Ratajczak; Andrzej K Ciechanowicz; Jolanta Kucharska-Mazur; Jerzy Samochowiec
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-04-20       Impact factor: 5.067

Review 9.  CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.

Authors:  Magda Kucia; Kacper Jankowski; Ryan Reca; Marcin Wysoczynski; Laura Bandura; Daniel J Allendorf; Jin Zhang; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

10.  Platelet factor 4 regulates megakaryopoiesis through low-density lipoprotein receptor-related protein 1 (LRP1) on megakaryocytes.

Authors:  Michele P Lambert; Yuhuan Wang; Khalil H Bdeir; Yvonne Nguyen; M Anna Kowalska; Mortimer Poncz
Journal:  Blood       Date:  2009-07-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.